Ritten secures a $35 million Series B investment led by Five Elms Capital to expand its AI-driven behavioral health management platform.

Target Information

Ritten is an innovative AI-powered behavioral health management platform founded in 2020 and headquartered in Philadelphia, Pennsylvania. The company specializes in providing a unified system of record for behavioral health practitioners, encompassing electronic medical records (EMR), customer relationship management (CRM), and revenue cycle management (RCM) into a single, cohesive platform. This integration allows treatment providers to streamline operations, ensuring they can focus on delivering high-quality care while effectively managing their administrative tasks.

With a firm commitment to enhancing the quality of care in the behavioral health sector, Ritten serves a diverse range of clients — from single-site facilities to multi-state enterprises. Its platform is designed to support mental health and addiction treatment providers at all levels of care, addressing crucial operational needs and alleviating the burdens faced by clinical staff.

Industry Overview

The behavioral health industry in the United States is undergoing significant transformation, driven by an increasing demand for mental health and addiction services. As societal awareness of mental health issues grows, more individuals are seeking tr

View Source

Similar Deals

Redpoint Ventures Function Health

2025

Series B Medical & Diagnostic Laboratories United States of America
ARCH Venture Partners, GV (Google Ventures) Pelage Pharmaceuticals

2025

Series B Proprietary & Advanced Pharmaceuticals United States of America
Goldman Sachs Alternatives evolvedMD

2025

Series B Hospitals, Clinics & Primary Care Services United States of America
EQT Life Sciences, Sanofi Ventures SpliceBio

2025

Series B Bio Therapeutic Drugs United States of America
Accelmed Partners Acclaro Medical

2025

Series B Laser Equipment United States of America
Blue Owl Capital Latigo Biotherapeutics

2025

Series B Bio Therapeutic Drugs United States of America

Five Elms Capital

invested in

Ritten

in 2025

in a Series B deal

Disclosed details

Transaction Size: $35M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert